• Trump's assertion that tariffs have made the U.S. "very rich" is undercut by projections showing $1.2 trillion in revenue over 2026-35 offset by slower growth and consumer costs.
  • A recent Supreme Court ruling invalidated some tariffs under the International Emergency Economic Powers Act, narrowing their scope to metals, vehicles, and electronics as of February 20, 2026.
  • Economic growth remains resilient near 3% in 2026, boosted by AI investments and fiscal tailwinds, but inflation risks persist with projected short-run price increases of 0.6%.

In a defense of his protectionist trade policies, former President Donald Trump has reiterated that tariffs have made the United States "very rich," but recent analyses as of February 2026 reveal a more nuanced economic picture. While tariffs are projected to raise $1.2 trillion conventionally over the next decade, dynamic effects from slower growth are expected to cut net revenue to $1 trillion, according to people familiar with the matter. This comes as the Trump administration shows sensitivity to consumer impacts, delaying wood product tariff hikes to 2027 and considering reductions on steel, aluminum, and copper amid rising pass-through to inflation, evident in the PCE deflator.

Efforts to balance tariff revenue with economic stability have hit a snag following a Supreme Court ruling that invalidated some tariffs imposed under the International Emergency Economic Powers Act, reducing their scope as of late February. Remaining tariffs now primarily target metals, vehicles, and electronics, with projected short-run price increases of 0.6% translating to an average household loss of $800 and a long-run GDP contraction of 0.1%, or $30 billion annually. Without adjustments, these measures could exacerbate affordability concerns, particularly ahead of upcoming elections.

Economic growth remains resilient near 3% in 2026, bolstered by AI investments, robust consumer spending, and fiscal tailwinds such as $900 average tax refunds. However, inflation risks linger from tariff pass-through, with Goldman Sachs estimating a 1% rise from the second half of 2025 to the second half of 2026. Pharmaceuticals face potential 200% hikes by mid-2026, adding pressure on policymakers to mitigate broader economic drags. The administration has signaled flexibility, with delays on wood tariffs and reviews of metals duties, reflecting a strategic pivot to avoid pre-midterm affordability hits.

Unemployment is projected to rise by 0.3 percentage points, resulting in 550,000 fewer jobs by the end of 2026, while sectoral impacts vary: manufacturing output may increase by 1.2%, but construction could decline by 2.4% and agriculture by over 1%. Households face $600 to $800 in short-run income losses from price hikes, disproportionately affecting lower-income groups, with a $400 loss at the bottom quintile. Stakeholders in manufacturing stand to gain relatively, whereas agriculture, construction, and consumers bear the brunt of the economic shifts.

The political context underscores tariffs' alignment with Trump's National Security Strategy, which prioritizes balanced trade, supply chain security, reindustrialization, and a Western Hemisphere focus. Only 35% of threatened tariffs have been imposed, often via executive order, with delays aimed at cushioning economic impacts. The Supreme Court's limits on IEEPA use have prompted discussions of refunds, though their timing remains uncertain and may offset some of the 2026 growth drags. Public debate continues to center on tariff-inflation links, with administration adjustments indicating responsiveness to affordability concerns.

In the short term, temporary fiscal impulses from potential IEEPA refunds could offset 2026 economic drags, sustaining 3% growth with upside inflation risks if pass-through accelerates. Two Federal Reserve rate cuts are possible following the appointment of Kevin Warsh as Chair. Long-term outlooks suggest persistent 0.1% GDP shrinkage and sectoral reallocations favoring manufacturing, with aggressive repricing risks if tariffs on pharmaceuticals and other goods rise. Broader fiscal boosts, such as OBBB tax changes adding $200 billion to after-tax incomes in 2026, may further complicate the tariff narrative.

Correction: An earlier version of this article misstated the projected net revenue from tariffs; it is $1 trillion, not $1.2 trillion, after accounting for dynamic growth effects.